Literature DB >> 11470339

The efficacy of computer-tailored smoking cessation material as a supplement to nicotine patch therapy.

S Shiffman1, J A Paty, J M Rohay, M E Di Marino, J G Gitchell.   

Abstract

The study evaluated the efficacy of the Committed Quitters Program (CQP), a computer-tailored set of printed behavioral support materials offered free to purchasers of NicoDerm CQ patches, as a supplement to the nicotine patch and the standard brief User's Guide (UG) and audiotape. Callers to the CQP enrollment were randomized to either CQP (n=1854) or just the UG (n=1829). Abstinence and use of program materials were assessed by telephone interview at 6 and 12 weeks (the latter falling 2 weeks after patch use was to be discontinued). Considering all respondents, abstinence rates did not differ significantly between the UG and CQP groups. As expected, among those who reported they used their assigned materials (80.1% of the sample) smokers who received CQP demonstrated higher quit rates at both 6 weeks (38.8% v. 30.7%) and 12 weeks (18.2% v. 11.1%), compared to the UG group. Among those who used it, the Committed Quitters Program proved to be an effective behavioral treatment, improving quit rates over nicotine replacement therapy and a brief untailored written guide and audiotape.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470339     DOI: 10.1016/s0376-8716(00)00237-4

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  14 in total

1.  Design and pilot evaluation of an internet smoking cessation program.

Authors:  Leslie Lenert; Ricardo F Muñoz; Jackie Stoddard; Kevin Delucchi; Aditya Bansod; Steven Skoczen; Eliseo J Pérez-Stable
Journal:  J Am Med Inform Assoc       Date:  2003 Jan-Feb       Impact factor: 4.497

2.  Boosting population quits through evidence-based cessation treatment and policy.

Authors:  David B Abrams; Amanda L Graham; David T Levy; Patricia L Mabry; C Tracy Orleans
Journal:  Am J Prev Med       Date:  2010-03       Impact factor: 5.043

3.  A randomised control study of a fully automated internet based smoking cessation programme.

Authors:  L H G Swartz; J W Noell; S W Schroeder; D V Ary
Journal:  Tob Control       Date:  2006-02       Impact factor: 7.552

Review 4.  A vision of the next generation of behavioral therapies research in the addictions.

Authors:  Kathleen M Carroll; Bruce J Rounsaville
Journal:  Addiction       Date:  2007-06       Impact factor: 6.526

5.  Predictors of early versus late smoking abstinence within a 24-month disease management program.

Authors:  Lisa Sanderson Cox; Jo A Wick; Niaman Nazir; A Paula Cupertino; Laura M Mussulman; Jasjit S Ahluwalia; Edward F Ellerbeck
Journal:  Nicotine Tob Res       Date:  2011-01-13       Impact factor: 4.244

Review 6.  Tailoring nicotine replacement therapy: rationale and potential approaches.

Authors:  Jennifer B McClure; Gary E Swan
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

7.  A meta-analysis of computer-tailored interventions for health behavior change.

Authors:  Paul Krebs; James O Prochaska; Joseph S Rossi
Journal:  Prev Med       Date:  2010-06-15       Impact factor: 4.018

8.  Design and baseline characteristics from the KAN-QUIT disease management intervention for rural smokers in primary care.

Authors:  Lisa Sanderson Cox; Ana-Paula Cupertino; Laura M Mussulman; Niaman Nazir; K Allen Greiner; Jonathan D Mahnken; Jasjit S Ahluwalia; Edward F Ellerbeck
Journal:  Prev Med       Date:  2008-05-03       Impact factor: 4.018

9.  Screening experiments and the use of fractional factorial designs in behavioral intervention research.

Authors:  Vijay Nair; Victor Strecher; Angela Fagerlin; Peter Ubel; Kenneth Resnicow; Susan Murphy; Roderick Little; Bibhas Chakraborty; Aijun Zhang
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

10.  Improving adherence to web-based cessation programs: a randomized controlled trial study protocol.

Authors:  Amanda L Graham; Sarah Cha; George D Papandonatos; Nathan K Cobb; Aaron Mushro; Ye Fang; Raymond S Niaura; David B Abrams
Journal:  Trials       Date:  2013-02-17       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.